Acumen Hypotension Prediction Index – EV1000 Clinical Platform vs Avive Automated External Defibrillator

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

Tool A, the Acumen Hypotension Prediction Index, is a predictive monitoring system designed to anticipate and help manage hypotensive events in clinical settings using machine learning. In contrast, Tool B, the Avive Automated External Defibrillator, is an emergency interventional device for out-of-hospital cardiac arrest, utilizing AI for rhythm analysis and shock delivery. While both operate within critical care and cardiology, their core functionalities and target use cases are distinct, focusing on prevention versus immediate life-saving intervention.

Choose Acumen Hypotension Prediction Index – EV1000 Clinical Platform if…

Choose the Acumen Hypotension Prediction Index if your clinical environment requires proactive management of patient hemodynamics to prevent hypotensive events. This tool is ideal for anesthesiology or critical care settings where continuous, predictive monitoring up to 15 minutes in advance can guide timely interventions and improve patient outcomes. It provides valuable insights into the underlying causes of instability, such as preload, afterload, and contractility.

View Acumen Hypotension Prediction Index – EV1000 Clinical Platform →

Choose Avive Automated External Defibrillator if…

Choose the Avive Automated External Defibrillator if you need a highly connected, portable solution for responding to out-of-hospital cardiac arrest. This device is best suited for public spaces, workplaces, or community programs where rapid deployment, automated 911 integration, and seamless data transfer to EMS are critical for improving survival rates. Its remote monitoring capabilities also ensure device readiness and simplify maintenance.

View Avive Automated External Defibrillator →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform Avive Automated External Defibrillator
Pricing Unknown Contact avive solutions for pricing.
Deployment On-premise (integrated with EV1000 clinical platform and HemoSphere advanced monitoring platform) Physical device deployment in various public and private settings.
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Avive Automated External Defibrillator

The Avive Connect AED is designed for intuitive use by both trained and untrained individuals in emergency situations, featuring clear voice prompts and visual indicators. In contrast, the Acumen HPI is integrated into a complex clinical monitoring platform, requiring specialized training for healthcare professionals.

Clinical Value

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Acumen HPI offers significant clinical value by using machine learning to predict hypotensive events up to 15 minutes in advance, providing proactive insights into hemodynamic instability and potential causes. This predictive capability allows for earlier intervention, potentially preventing adverse outcomes. While the Avive AED is life-saving in cardiac arrest, it is a reactive intervention.

Pricing & Value

Tie

Both tools explicitly state 'contact for pricing,' offering no transparency into their cost structures. Without any specific pricing details or information on total cost of ownership for either, it is impossible to determine which offers better pricing or value.

Enterprise Readiness

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Acumen HPI, developed by Edwards Lifesciences, is designed for seamless integration within established hospital IT infrastructure and existing advanced monitoring platforms (HemoSphere/EV1000). Its explicit HIPAA compliance and focus on critical care settings within a hospital environment demonstrate a clear readiness for enterprise healthcare deployment. Tool B, while robust for fleet management, targets a broader, more distributed deployment model.

Innovation

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

The core innovation of Acumen HPI lies in its application of machine learning to predict hypotensive events up to 15 minutes in advance, offering proactive clinical intervention based on real-time physiological data. This predictive capability and the provision of insights into underlying hemodynamic causes represent a more advanced and novel application of AI in clinical decision support compared to Tool B's innovative connectivity features for an existing device.

Support & Docs

Tie

Both companies provide accessible documentation for their respective user bases. Avive offers user-friendly manuals and a help center for a broad audience, while Edwards Lifesciences, as a large medical device company, is expected to have extensive support and documentation for its complex clinical platform, as evidenced by detailed FAQs and regulatory filings. Without more specific comparative details on the breadth and responsiveness of their support services, it is difficult to declare a definitive winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform Avive Automated External Defibrillator
Tool Name Acumen Hypotension Prediction Index u2013 EV1000 Clinical Platform Avive Automated External Defibrillator
Company Edwards Lifesciences Avive Solutions
Primary Function Uses machine learning to predict hypotensive events up to 15 minutes in advance, providing clinicians with insights into hemodynamic instability and potential causes to help reduce intraoperative hypotension. Portable, FDA-cleared automated external defibrillator featuring advanced connectivity and RealConnect Technology for seamless 911 integration and remote monitoring, designed to improve survival rates from out-of-hospital cardiac arrest.
Key Predictive/Connectivity Feature HPI Parameter (0-100 likelihood score); Predicts hypotension up to 15 minutes in advance. Full suite of connectivity: Cellular, WiFi, GPS, and Bluetooth; RealConnect Technology for 911 integration via RapidSOS partnership.
Target Medical Specialties Anesthesiology, Critical Care, Emergency Medicine Cardiology, Critical Care, Emergency Medicine

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform and Avive Automated External Defibrillator.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Tool A, the Acumen HPI, integrates directly into the Edwards Lifesciences HemoSphere Advanced Monitoring Platform, providing continuous, real-time hemodynamic insights and hypotension prediction within the OR or ICU setting. Tool B, the Avive Connect AED, is a portable device designed for rapid deployment in out-of-hospital cardiac arrest scenarios, integrating with 911/EMS systems via its RealConnect Technology to streamline emergency response.
The Acumen HPI uses a machine learning-based algorithm to predict hypotensive events up to 15 minutes in advance, providing a 0-100 likelihood score (HPI Parameter) to clinicians. It also offers Smart Alerts for trending hypotension and insights into the potential causes through its Relationship View screen, which displays preload, afterload, and contractility insights.
The Avive Connect AED utilizes RealConnect Technology, including cellular, WiFi, GPS, and Bluetooth, to facilitate Rapid Incident Data Transfer (ECG, usage timestamps, shock analysis) directly to 911/EMS via its RapidSOS partnership. This connectivity also enables automated remote monitoring and maintenance of the AEDs, providing an ongoing record of device status and usage.
For the Acumen HPI, clinicians would need to learn to interpret the HPI parameter, Smart Alerts, and Relationship View within the existing Edwards monitoring platform, which integrates with dedicated sensors. The Avive Connect AED is designed with voice prompts and visual indicators for both trained and untrained users, suggesting a relatively low learning curve for basic operation during an emergency.
Deploying Acumen HPI across multiple sites would involve integrating the software with existing or new Edwards Lifesciences HemoSphere Advanced Monitoring Platforms and ensuring staff training on its advanced hemodynamic monitoring features. For the Avive Connect AED, multi-site rollout would focus on strategic placement of the physical devices, configuring their advanced connectivity for remote monitoring, and establishing protocols for data transfer to local EMS across various locations.
The Acumen HPI is specifically designed for proactive management of hemodynamic instability in high-acuity settings such as the operating room or intensive care unit, particularly for patients undergoing surgery or those critically ill requiring continuous monitoring. The Avive Connect AED is optimized for improving survival rates from out-of-hospital cardiac arrest, making it ideal for public access defibrillation programs, workplaces, and community settings where rapid response to sudden cardiac arrest is critical.

Backers

Who funded each tool's parent company.

Avive Automated External Defibrillator

AI Tool Finder
AI-powered search. Results may not be comprehensive.